Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/10/2025 ,inter alia, to consider and approve As attached.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shukra Pharmaceuticals has called a Board Meeting on October 03, 2025 to consider and approve a preferential issue of warrants to the company's Promoters, in line with SEBI (ICDR) Regulations, 2018. The Board will also fix the relevant date for this preferential issue and decide the date, time, and venue for an Extraordinary General Meeting (EGM) to seek shareholder approval. A scrutinizer will be appointed to oversee the remote e-voting and voting process at the EGM. The company is based in Ahmedabad and has its registered office at Bodakdev. Shareholder approval and other regulatory clearances will be required before the warrants can be issued.
This is a promoter-led capital infusion plan, which may be seen as a positive sign of promoter confidence but can also lead to equity dilution once warrants are exercised. Retail shareholders should watch for issue price, conversion terms, and how many warrants are being issued, as these details will shape the stock's near-term sentiment.